diabetes
NHS to pilot artificial pancreas for type 1 diabetes
June 17, 2021NHS, diabetes, insulin, technology, wearable technology
The NHS has announced that artificial pancreases will be available to patients with type 1 diabetes, with up to 1,000 …
Eli Lilly to collaborate with diabetes tech companies on insulin pen
May 10, 2021Sales and Marketing Eli Lilly, diabetes
Eli Lilly has signed strategic international agreements with four companies – Dexcom, Glooko, myDiabby Healthcare, and Roche – with the …
Arecor receives £2.8m grant for rapid insulin product
March 31, 2021Research and Development diabetes, insulin
Arecor has announced today that it has received a £2.8 million grant from Innovate UK, to support the Phase II …
ViaCyte and Gore collaborate on new diabetes treatments
March 3, 2021Research and Development Type 1 diabetes, diabetes, diabetes treatment, gore, viacyte
Clinical stage medicine company ViaCyte have extended their collaboration with materials science organisation Gore to develop new candidates for the …
Eli Lilly’s diabetes drug tirzepatide reduces blood glucose and weight in Phase III trials
February 18, 2021Eli Lilly, diabetes
Eli Lilly’s tirzepatide led to significant haemoglobin A1C (HbA1C) and body weight reductions from baseline in adults with type 2 …
Lilly’s tirzepatide generates significant reductions in weight and blood sugar in type 2 diabetes patients
December 10, 2020Research and Development Eli Lilly, diabetes, tirzepatide
Eli Lilly has announced new data for its glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide, showing …
The December 2020 issue of Pharmafocus is available to read free online now!
November 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing
The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …
Sun Pharma issues recall of its generic diabetes drug in US market
October 12, 2020Sales and Marketing FDA, diabetes, recall
Sun Pharma is recalling 747 bottles of its generic diabetes drug Riomet ER in the US.This is due to an …
Novo Nordisk launches new Rybelsus pill for type 2 diabetes in the UK
September 2, 2020Research and Development Novo Nordisk, diabetes, type 2, type 2 diabetes
Novo Nordisk’s new type 2 diabetes treatment Rybelsus is now available for doctors and physicians in the UK to prescribe …
Arthritis drug Abatacept could be used to treat type 1 diabetes
August 11, 2020Manufacturing and Production diabetes, insulin, tye 1, type 2
People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds. Researchers at …
Eli Lilly asks for a $24 million tax break for diabetes care facility expansion in Indianapolis
July 24, 2020Medical Communications Eli Lilly, Humalog, diabetes, insulin
Insulin manufacturer Eli Lilly has requested a $24 million tax break over the next 10 years as an investment into …
Drug industry suing to overturn Minnesota insulin affordability law
July 2, 2020Business Services diabetes, insulin, type 1, type 2
The drug industry is suing to overturn a Minnesota law that requires companies to provide emergency insulin to diabetics who …
New data from diabetes prevention programme shows a reduction of type 2 diabetes
June 17, 2020Research and Development diabetes, type 2 diabetes
The Diabetes Prevention Program Outcomes Study (DPPOS) of 2,000 people showed a significant reduction in the participants’ risk of developing …
Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes
June 12, 2020Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes
Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …
Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS
May 20, 2020Research and Development COVID-19, Diabetics, coronavirus, diabetes
People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …
